Tag: Bayer

Not intended for U.S. and UK Media Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by ...

Leverkusen, April 28, 2023 – Bayer strengthened its position as a successful life science company in 2022 despite the difficult ...

31 January 2023 | 08:59 AM Europe/Amsterdam 2023-0021 Pheromone-based crop protection products help farmers control pests in an environmentally friendly ...

Not intended for U.S. and U.K. Media Berlin, January 10, 2023 – On the occasion of the 41st J.P. Morgan ...

Leverkusen/Kyiv, April 5, 2023 – Bayer has revealed an investment of overall 60 million euros from 2023 onwards in its ...

Leverkusen, April 3, 2023 – Bayer AG has established a Bioethics Council consisting of internationally renowned experts, to provide broad ...

Leverkusen, March 21, 2023 – Bayer is launching its new water strategy at the UN 2023 Water Conference in New ...

01 March 2023 | 07:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Submission to the Ministry of ...

Not intended for U.S. and UK Media Berlin, June 22, 2023 – Bayer announced today the initiation of FINE-ONE, a ...

Berlin, May 16, 2023 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...